Truist Financial Corp grew its holdings in shares of Core Laboratories (NYSE:CLB – Get Rating) by 5.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 430,188 shares of the oil and gas company’s stock after buying an additional 21,362 shares during the period. Truist Financial Corp owned 0.93% of Core Laboratories worth $13,607,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Core Laboratories by 47.8% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,512 shares of the oil and gas company’s stock worth $145,000 after purchasing an additional 2,105 shares in the last quarter. Teacher Retirement System of Texas bought a new stake in Core Laboratories during the fourth quarter worth approximately $200,000. Profund Advisors LLC raised its holdings in Core Laboratories by 12.9% during the fourth quarter. Profund Advisors LLC now owns 14,496 shares of the oil and gas company’s stock worth $323,000 after purchasing an additional 1,652 shares in the last quarter. First Trust Advisors LP bought a new stake in Core Laboratories during the fourth quarter worth approximately $532,000. Finally, SG Americas Securities LLC raised its holdings in Core Laboratories by 20.0% during the fourth quarter. SG Americas Securities LLC now owns 28,526 shares of the oil and gas company’s stock worth $636,000 after purchasing an additional 4,750 shares in the last quarter. 92.56% of the stock is currently owned by institutional investors.
NYSE CLB opened at $18.73 on Monday. The stock has a market capitalization of $867.35 million, a P/E ratio of 89.19 and a beta of 2.74. Core Laboratories has a 1 year low of $17.35 and a 1 year high of $38.16. The business’s fifty day moving average is $23.87 and its two-hundred day moving average is $26.76. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.54 and a current ratio of 2.03.
Core Laboratories (NYSE:CLB – Get Rating) last posted its quarterly earnings data on Wednesday, April 27th. The oil and gas company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.02. Core Laboratories had a net margin of 2.04% and a return on equity of 18.28%. The firm had revenue of $115.30 million for the quarter, compared to analysts’ expectations of $111.63 million. During the same period in the previous year, the company posted $0.15 EPS. On average, research analysts forecast that Core Laboratories will post 0.69 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 31st. Shareholders of record on Monday, May 9th were given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.21%. The ex-dividend date of this dividend was Friday, May 6th. Core Laboratories’s payout ratio is 19.05%.
CLB has been the topic of several recent analyst reports. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a report on Wednesday, May 11th. Piper Sandler cut Core Laboratories from a “neutral” rating to an “underweight” rating and upped their price target for the company from $19.50 to $21.30 in a report on Monday, April 18th. Finally, Morgan Stanley upped their price target on Core Laboratories from $30.00 to $35.00 and gave the company an “equal weight” rating in a report on Monday, April 11th.
Core Laboratories Company Profile (Get Rating)
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients’ reservoirs.
Further Reading
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLB – Get Rating).
Receive News & Ratings for Core Laboratories Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Core Laboratories and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net